Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | SYK | P43405 | 1/20 | 0.57 |
| ▸ | CTSS | P25774 | 4/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | KLK7 | P49862 | 2/20 | 0.48 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 3/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28915565 | 0.88 | PPARA (0.55) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL28578904 | 0.88 | PPARA (0.55) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL28578906 | 0.88 | PPARA (0.55) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL23574227 | 0.87 | PPARA (0.59) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL29295304 | 0.86 | PPARA (0.58) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL4744957 | 0.86 | PPARA (0.58) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL397978 | 0.86 | PPARA (0.58) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL21128729 | 0.85 | PPARA (0.57) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL28387647 | 0.84 | PPARA (0.56) | PPARASYKCTSSPPARGKLK7 | |
| SCHEMBL28302143 | 0.81 | PPARA (0.54) | PPARASYKCTSSPPARGKLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3023108-B1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU KOGYO CO LTD (JP) | 2021-04-07 | — | — | EP | disclosed |
| US-20200155694-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200155694-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | CSGALNACT1, CD44, GUSB | PPARA 2841/4885SYK 2962/4885CTSS 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.